Business Context and Reporting Period
This Form 8-K reports on the 2014 Annual Meeting of Stockholders held on September 10, 2014, by Oculus Innovative Sciences, Inc. (Note: The request metadata lists "Sonoma Pharmaceuticals, Inc.", but the filing text explicitly identifies the registrant as Oculus Innovative Sciences, Inc.). The report details the voting results for three proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding corporate governance events rather than a financial statement.
Material Changes and Voting Results
The following voting outcomes were reported as final:
- Shareholder Participation: Of 8,475,265 shares entitled to vote, 6,256,953 shares were present or represented by proxy.
- Proposal 1 (Election of Class III Director): Jerry McLaughlin was elected. Votes cast: 932,856 For; 648,341 Withheld.
- Proposal 2 (Advisory Vote on Executive Compensation): The vote was non-binding. Votes cast: 804,651 For; 739,185 Against; 37,361 Abstain.
- Proposal 3 (Ratification of Auditor): Marcum LLP was ratified as the independent registered public accounting firm for the fiscal year ending March 31, 2015. Votes cast: 5,795,093 For; 272,586 Against; 189,274 Abstain; 0 Broker Non-Votes.
Guidance, Outlook, and Management Commentary
Management noted that based on the results of the advisory vote on executive compensation (Proposal 2), the Compensation Committee of the Board of Directors will review the Company's 2014 compensation policies and practices to consider the input received from stockholders. No specific financial guidance or outlook was provided in this filing.
Important Facts for Investor Verification
- Verify the registrant name: The filing is for Oculus Innovative Sciences, Inc., not Sonoma Pharmaceuticals, Inc.
- Review the significant "Against" vote count (739,185) on the executive compensation advisory proposal, which indicates notable shareholder dissent.
- Confirm the appointment of Marcum LLP as the auditor for the fiscal year ending March 31, 2015.
- Note that the filing contains no financial performance data; refer to the most recent 10-K or 10-Q for financial metrics.